chr6-45437964-A-G
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PP2PP3_ModeratePP5_Moderate
The NM_001024630.4(RUNX2):c.598A>G(p.Thr200Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001024630.4 missense
Scores
Clinical Significance
Conservation
Publications
- cleidocranial dysplasia 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RUNX2 | NM_001024630.4 | c.598A>G | p.Thr200Ala | missense_variant | Exon 5 of 9 | ENST00000647337.2 | NP_001019801.3 | |
| RUNX2 | NM_001369405.1 | c.556A>G | p.Thr186Ala | missense_variant | Exon 3 of 7 | NP_001356334.1 | ||
| RUNX2 | NM_001015051.4 | c.598A>G | p.Thr200Ala | missense_variant | Exon 5 of 8 | NP_001015051.3 | ||
| RUNX2 | NM_001278478.2 | c.556A>G | p.Thr186Ala | missense_variant | Exon 3 of 6 | NP_001265407.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cleidocranial dysostosis Pathogenic:1Other:1
- -
- -
Cleidocranial dysplasia 1, forme fruste, dental anomalies only Pathogenic:1
- -
not provided Pathogenic:1
This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 200 of the RUNX2 protein (p.Thr200Ala). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with cleidocranial dysplasia (PMID: 10545612; Invitae). It has also been observed to segregate with disease in related individuals. This variant is also known as CBFA1 T200A. ClinVar contains an entry for this variant (Variation ID: 9304). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RUNX2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change does not substantially affect RUNX2 function (PMID: 10545612, 23558979). This variant disrupts the p.Thr200 amino acid residue in RUNX2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19767586). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at